Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Genomic Sequencing Sheds New Light on Advanced Prostate Cancer
By Stephanie Murg, Managing Director, G2 Intelligence A precision medicine approach is yielding valuable new insights into a common, aggressive form of prostate cancer. Researchers sequenced the DNA and RNA of tumor biopsy samples from 150 men with metastatic,...
Palmetto GBA Issues Proposed Draft LCD for Oncotype DX® Prostate Cancer Assay
By Kelly A. Briganti, Editorial Director, G2 Intelligence Prostate cancer testing has received significant attention lately as the industry seeks to find reliable ways of identifying the appropriate treatment strategy for patients diagnosed with such cancer. A new...
Report Indicates Patients Seek Transparency, Choices and Convenience in Health Care Billing
By Kelly A. Briganti, Editorial Director, G2 Intelligence A new report released this month by PricewaterhouseCoopers (PwC) describes the U.S. health care industry's billing and payment system as "a horse-and-buggy in a world contemplating driverless cars." The...
Many Not Getting Colorectal, Cervical Cancer Screenings
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Many adults are not getting recommended, routine screenings for cervical and colorectal cancer, according to the U.S. Centers for Disease Control and Prevention (CDC). Screening rates for...